Skip to Content

253 (Pramipexole Dihydrochloride Extended-Release 1.5 mg)

Pill with imprint 253 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 1.5 mg. It is supplied by Par Pharmaceutical Inc.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 253

Pramipexole dihydrochloride extended-release 1.5 mg 253

Pramipexole Dihydrochloride Extended-Release

Imprint
253
Strength
1.5 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc

Labelers / Repackagers

NDC CodeLabeler / Repackager
10370-0253 Anchen Pharmaceuticals, Inc.
42291-0555 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "253"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.